c-LEcta: OFB Starts Construction Work for “BioSquare Leipzig” Technology Campus

Frankfurt, Germany–(BUSINESS WIRE)–OFB Projektentwicklung has started the first phase of construction of the “BioSquare Leipzig” on an area of ​​around 11,600 m² of construction site 6a on the street “Alte Messe”. The symbolic groundbreaking ceremony on September 22, 2022 took place in the presence of Thomas Dieberg (Mayor for Urban Development and Construction of the City of Leipzig), Dr. Marc Struhalla (Managing Director of c-LEcta GmbH) and Dr. Christoph Wiechmann (Leipzig office manager at OFB project development). The ceremony marks the start of a modern campus for biotechnology and life sciences, which consists of several buildings. The excavation of around 35,000 m³ of soil should be completed by mid-November this year.

As early as February 2022, a façade competition was held for the project with five architectural offices and a jury consisting of politicians, architects, scientists, the tenant c-LEcta and OFB. The Leipzig office KLM Architekten und Ingenieure GmbH was commissioned to plan the first phase of construction with the façade design.

Above ground, the first construction phase consists of two separate buildings with a total of around 18,500 m² of rental space. Five floors are planned for Building A, which will be used in the future by the biotechnology company c-LEcta GmbH and will have around 10,500 m² of rental space above ground.

Since the company was founded in 2004, c-LEcta has been located on the site of the “Alte Messe” and moved into its headquarters in the BioCube in 2012. In the meantime, c-LEcta has developed into a leading global player in industrial biotechnology. In 2021, c-LEcta worked with over 400 customers from more than 40 countries in the food and pharmaceutical industry and again significantly increased sales compared to the previous year. As a result, the number of employees has also increased rapidly over the years. Since 2018 alone, the number has doubled to 120 employees. Further growth in the workforce is also planned for the coming years, so that there will not be enough space available for the office and laboratory space in the existing building.

Also Read :  Elon Musk Has a Gloomy Prediction About the Economy

The neighboring Building B in the direction of Prager Strasse has seven floors and will therefore offer a view over the old exhibition center after completion. The slight offset of the second building creates a forecourt that provides inviting access to building B with a good quality of stay. There will also be a shared underground car park with around 110 parking spaces.

Completion of the construction work for c-Lecta’s new corporate headquarters is scheduled for the first half of 2025. A further 8,000 m² of rental space will be created in the second building of the first construction phase. With storey heights of four meters and a modern construction pattern, both buildings offer maximum flexibility in use, so that both office space and laboratory space can be realised.

“The BioSquare project development underscores the importance of Leipzig as an innovation location for biotechnology and life sciences. We want to keep innovative companies from these future-oriented sectors at the location and attract new ones. Of course, we are particularly pleased that the c-LEcta, a Leipzig success story, is entering the first construction phase,” says the mayor and city council for urban development and building in the city of Leipzig, Thomas Dieberg.

Also Read :  Zhengzhou, China: Protesters at Foxconn factory clash with police, videos show

“The groundbreaking ceremony for our new headquarters in Leipzig is of course a very special moment. In 2025 we will move into a high-tech building with the most modern workplaces and laboratories. In this way, we not only secure sufficient space for further development in the long term, but also offer a state-of-the-art design concept for our employees. Cooperation, concentrated work and regeneration go hand in hand. We are pleased to be able to continue writing our history at our home location,” he emphasized dr Marc Struhalla, CEO of the tenant c-LEcta.

dr Christoph Wiechmann, head of the OFB office in LeipzigShe is also happy: “It’s great to see that the excavators are now turning and the realization phase of BioSquare has begun. The “Alte Messe” has made a name for itself as a location for innovative companies. On our campus, we offer research institutions and technology companies completely new development opportunities and perfect framework conditions.”

The project area is within sight of the well-known double M of the Leipzig Sample Fair. The neighboring S-Bahn station “Völkerschlachtdenkmal” and several tram and bus lines offer very good public transport connections. The ring road can also be reached in less than five minutes. Several innovative research institutions and companies such as the Fraunhofer IZI, the Max Planck Institute, Bio-City or the German Center for Integrative Biodiversity Research (iDiv) have settled at the “Alte Messe” site in recent years.


OFB Projektentwicklung GmbH has been in the real estate business for over 60 years. And is still as committed as on day one. As a subsidiary of Landesbank Hessen-Thüringen and part of the Helaba real estate group, the focus is on high-quality and sustainable large-scale properties. Project development, project management and real estate management are our passion.

Also Read :  Stock-market investors brace for busiest week of earnings season. Here's how it stacks up so far.

At our headquarters in Frankfurt/Main and in our branches in Berlin, Erfurt, Munich, Düsseldorf and Leipzig, around 140 employees implement successful real estate projects throughout Germany. In doing so, we want to work harder than others – and therefore already take into account the interaction of economic, ecological and social components when planning our projects. The goal: to further develop our projects and ourselves.


About c-LEcta

c-LEcta is a global biotechnology company specializing in the development, production and sale of enzyme products. The company uses best-in-class enzyme engineering and production technologies to offer its partners in the food and pharmaceutical industries superior biotechnological solutions for innovative industrial applications. Product development is based on the proprietary enzyme technology platform ENESYZ® and is carried out both internally and in close collaboration with industrial partners worldwide. c-LEcta supplies its products to more than 400 customers in over 40 countries. c-LEcta currently employs more than 120 people at its headquarters in Leipzig.

c-LEcta is part of the Kerry Group. Kerry is the world’s leading flavor and nutrition partner for the food, beverage and pharmaceutical markets. Employing 22,000 people in over 150 locations, the company leverages its wide range of ingredient solutions to partner with its customers to innovate and create great-tasting products with enhanced nutritional value and functionality, while ensuring a better impact on the planet.

Source link